Analyst: Selling XRP Now Risks Missing Long-Term Institutional Adoption
Wall Street analyst Linda P. Jones argues XRP should be seen as a network-linked asset tied to Ripple’s institutional payments infrastructure rather than a retail-driven meme token. Jones compares XRP’s current phase to early-stage Berkshire Hathaway, warning that selling now risks missing outsized long-term gains as Ripple’s enterprise integrations (for example, SBI Holdings) and regulatory clarity develop. Price context: XRP fell from a July high near $3.65 to about $1.94 (roughly a 48% decline) and sits roughly 50% below its all-time high near $3.84. Despite the pullback, XRP-linked spot ETFs have continued to collect assets, surpassing $60 million AUM as of Dec. 17, though analysts note ETF inflows don’t always produce immediate spot buying due to settlement timing. Supporters point to growing institutional demand and potential regulatory catalysts (e.g., clarity from U.S. lawmakers) as triggers for a re-rating; critics cite technical weakness and broader market headwinds that could delay any rally. This is opinion-based commentary and not investment advice.
Neutral
The net effect of the coverage is neutral for XRP price in the near term but potentially bullish long term. Arguments for a bullish re-rating stem from institutional adoption (notably integrations like SBI) and ongoing inflows into XRP-linked spot ETFs, which signal growing demand and can support a later price recovery if regulatory clarity advances. Offsetting this, the token has shown significant recent downside (≈48% from the July high) and remains about 50% below its all-time peak; technical weakness and macro market headwinds could prolong consolidation or further declines. ETF inflows are positive but may not immediately translate to spot buying because of settlement delays. For traders: expect elevated volatility. Short-term traders should watch price structure, volume, and ETF flow reports for liquidity shocks. Swing and position traders can consider the adoption narrative as a long-duration catalyst but should manage risk given regulatory and technical uncertainty.